- Home
- VRAX vs ALLR Comparison
VRAX vs ALLR Comparison
Compare VRAX & ALLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRAX
- ALLR
- Stock Information
- Founded
- VRAX 2013
- ALLR 2004
- Country
- VRAX United Kingdom
- ALLR United States
- Employees
- VRAX N/A
- ALLR N/A
- Industry
- VRAX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- ALLR Biotechnology: Pharmaceutical Preparations
- Sector
- VRAX Health Care
- ALLR Health Care
- Exchange
- VRAX Nasdaq
- ALLR Nasdaq
- Market Cap
- VRAX 4.7M
- ALLR 4.0M
- IPO Year
- VRAX 2022
- ALLR N/A
- Fundamental
- Price
- VRAX $0.98
- ALLR $0.85
- Analyst Decision
- VRAX Strong Buy
- ALLR
- Analyst Count
- VRAX 1
- ALLR 0
- Target Price
- VRAX $3.00
- ALLR N/A
- AVG Volume (30 Days)
- VRAX 67.1K
- ALLR 564.1K
- Earning Date
- VRAX 02-05-2025
- ALLR 08-04-2025
- Dividend Yield
- VRAX N/A
- ALLR N/A
- EPS Growth
- VRAX N/A
- ALLR N/A
- EPS
- VRAX N/A
- ALLR N/A
- Revenue
- VRAX $84,872.00
- ALLR N/A
- Revenue This Year
- VRAX $5,169.18
- ALLR N/A
- Revenue Next Year
- VRAX $66.97
- ALLR N/A
- P/E Ratio
- VRAX N/A
- ALLR N/A
- Revenue Growth
- VRAX 7.03
- ALLR N/A
- 52 Week Low
- VRAX $0.82
- ALLR $0.61
- 52 Week High
- VRAX $9.00
- ALLR $17.35
- Technical
- Relative Strength Index (RSI)
- VRAX 44.60
- ALLR 39.03
- Support Level
- VRAX $0.91
- ALLR $0.78
- Resistance Level
- VRAX $1.03
- ALLR $0.93
- Average True Range (ATR)
- VRAX 0.08
- ALLR 0.07
- MACD
- VRAX -0.00
- ALLR -0.02
- Stochastic Oscillator
- VRAX 24.46
- ALLR 18.72
About VRAX Virax Biolabs Group Limited
Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes and Human Papillomavirus.
About ALLR Allarity Therapeutics Inc.
Allarity Therapeutics Inc is a clinical-stage, precision medicine company. The company is actively advancing a pipeline of in-licensed oncology therapeutics for patients with difficult-to-treat cancers. Its Drug Response Predictor (DRP) technology refines patient selection and improves clinical outcomes. Its pipeline product includes Dovitinib, Stenoparib, Ixempra, and other formulations.